Stepan reports Q4 net income growth amid mixed EBITDA

Stepan Company (NYSE:SCL), a global manufacturer of specialty chemicals including surfactants, polymers and specialty products for consumer and industrial markets, reported fourth-quarter and full-year 2025 results on February 23, 2026, highlighting resilience in a challenging chemical industry environment marked by raw material volatility and demand fluctuations.

For the fourth quarter ended December 31, 2025, Stepan posted net income of $5 million, up 49% from the prior-year period.

Adjusted EBITDA came in at $33.8 million, down 3% year-over-year, reflecting continued margin pressures from lower average selling prices and softer volumes in certain end markets, partially offset by cost discipline and productivity gains.

Full-year 2025 results showed net income of $46.9 million, down 7% from 2024, on net sales of $2.332 billion, an increase of 7% driven by higher volumes and favorable product mix in key segments.

EBITDA rose 11% to $208 million, while adjusted EBITDA increased 6% to $198.9 million.

Elsewhere, management highlighted progress in cost reduction and efficiency initiatives, announcing the launch of Project Catalyst, a company-wide program targeting approximately $100 million in pre-tax savings over the next two years through supply chain optimization, manufacturing productivity enhancements, organizational streamlining, and procurement improvements.

For 2026, Stepan expects adjusted EBITDA growth year-over-year and anticipates generating positive free cash flow, supported by the benefits of Project Catalyst, stabilizing raw material costs, and anticipated recovery in demand across consumer, agricultural, and industrial end markets.